Abstract:Increasing evidence has indicated critical roles of nicotinamide adenine dinucleotide, oxidized form (NAD+) in various biological functions. NAD+ deficiency has been found in models of a number of diseases such as cerebral ischemia, myocardial ischemia, and diabetes, and in models of aging. Applications of NAD+ or other approaches that can restore NAD+ levels are highly protective in these models of diseases and aging. NAD+ produces its beneficial effects by targeting at multiple pathological pathways, including attenuating mitochondrial alterations, DNA damage, and oxidative stress, by modulating such enzymes as sirtuins, glyceraldehyde-3-phosphate dehydrogenase, and AP endonuclease. These findings have suggested great therapeutic and nutritional potential of NAD+ for diseases and senescence. Recent Advances: Approaches that can restore NAD+ levels are highly protective in the models of such diseases as glaucoma. The NAD+ deficiency in the diseases and aging results from not only poly(ADP-ribose) polymerase-1 (PARP-1) activation but also decreased nicotinamide phosphoribosyltransferase (Nampt) activity and increased CD38 activity. Significant biological effects of extracellular NAD+ have been found. Increasing evidence has suggested that NAD+ deficiency is a common central pathological factor in a number of diseases and aging. Critical Issues and Future Directions: Future studies are required for solidly establishing the concept that "NAD+ deficiency is a common central pathological factor in a number of disease and aging." It is also necessary to further investigate the mechanisms underlying the NAD+ deficiency in the diseases and aging. Preclinical and clinical studies should be conducted to determine the therapeutic potential of NAD+ for the diseases and aging.

NAD+ homeostasis and its role in exercise adaptation: A comprehensive review

NAD+ centric mechanisms and molecular determinants of skeletal muscle disease and aging

NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential

NAD+ homeostasis in health and disease

Mechanisms of the NAD+ salvage pathway in enhancing skeletal muscle function

Nicotinamide riboside-A missing piece in the puzzle of exercise therapy for older adults?

A need for NAD+ in muscle development, homeostasis, and aging

Acute exercise boosts NAD + metabolism of human peripheral blood mononuclear cells

NAD+ metabolism and its roles in cellular processes during ageing

NAD<SUP>+</SUP> and cardiovascular diseases

Targeting NAD+ in Metabolic Disease: New Insights Into an Old Molecule

NAD+ metabolism and therapeutic strategies in cardiovascular diseases

Effect of Exercise and Oral Niacinamide Mononucleotide on Improving Mitochondrial Autophagy in Alzheimer's Disease

NAD+ Deficiency Is a Common Central Pathological Factor of a Number of Diseases and Aging: Mechanisms and Therapeutic Implications

Regulation of and challenges in targeting NAD + metabolism

Regular exercise effectively protects against the aging-associated decline in skeletal muscle NAD content

Implications of NAD+ boosters in translational medicine

Emerging interactions between mitochondria and NAD+ metabolism in cardiometabolic diseases

Implications of altered NAD metabolism in metabolic disorders

The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update

NAD+ and Its Possible Role in Gut Microbiota: Insights on the Mechanisms by Which Gut Microbes Influence Host Metabolism